Parameterization of a Non-local Crystal Plasticity Model for Tempered Lath Martensite Using Nanoindentation and Inverse Method

Autor: Jenni K. Engels, Napat Vajragupta, Alexander Hartmaier

Publikováno v: Frontiers in Materials, Vol 6 (2019)

Crystal plasticity (CP) models have proven to accurately describe elasto-plastic behavior on micro- and nanometer length scales in numerous applications. However, their parameterization requires a series of experiments and inverse analysis of the res

Externí odkaz: https://doaj.org/article/0bba9d8a046b46f99028792f2ed5e119

Supplementary Table 1 from CYP3A4*22 Genotype and Systemic Exposure Affect Paclitaxel-Induced Neurotoxicity

Autor: Ron H.N. van Schaik, Ron H.J. Mathijssen, Jaap Verweij, Erik A.C. Wiemer, Ferry A.L.M. Eskens, Frederike K. Engels, Peter de Bruijn, Pleun J. de Raaf, Bronno van der Holt, Lena E. Friberg, Alex Sparreboom, Jason A. Sprowl, Laure Elens, Anne-Joy M. de Graan

PDF file - 45K, Hardy Weinberg equilibrium.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ec40f1a9bdd542536d9278b6920efa6
https://doi.org/10.1158/1078-0432.22446617.v1

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group

Autor: Esmée C de Baat, Elvira C van Dalen, Renée L Mulder, Melissa M Hudson, Matthew J Ehrhardt, Frederike K Engels, Elizabeth A M Feijen, Heynric B Grotenhuis, Jan M Leerink, Livia Kapusta, Gertjan J L Kaspers, Remy Merkx, Luc Mertens, Roderick Skinner, Wim J E Tissing, Florent de Vathaire, Paul C Nathan, Leontien C M Kremer, Annelies M C Mavinkurve-Groothuis, Saro Armenian

Publikováno v: de Baat, E C, van Dalen, E C, Mulder, R L, Hudson, M M, Ehrhardt, M J, Engels, F K, Feijen, E A M, Grotenhuis, H B, Leerink, J M, Kapusta, L, Kaspers, G J L, Merkx, R, Mertens, L, Skinner, R, Tissing, W J E, de Vathaire, F, Nathan, P C, Kremer, L C M, Mavinkurve-Groothuis, A M C & Armenian, S 2022, ' Primary cardioprotection with dexrazoxane in patients with childhood cancer who are expected to receive anthracyclines : recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group ', The Lancet Child and Adolescent Health, vol. 6, no. 12, pp. 885-894 . https://doi.org/10.1016/S2352-4642(22)00239-5
The Lancet Child & Adolescent Health, 6, 885-894
The Lancet Child & Adolescent Health, 6, 12, pp. 885-894

Item does not contain fulltext Survivors of childhood cancer are at risk of anthracycline-induced cardiotoxicity, which might be prevented by dexrazoxane. However, concerns exist about the safety of dexrazoxane, and little guidance is available on it

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e933dd197d23cbe7070b694086dff1e7
https://doi.org/10.1016/S2352-4642(22)00239-5

94P Patient quality of life (QoL) from the GeparX trial on the addition of denosumab (Dmab) added to two different nab-paclitaxel (nP) regimens as neoadjuvant chemotherapy (NACT) in primary breast cancer (BC)

Autor: M. Reinisch, J-U. Blohmer, T. Link, M. Just, M. Untch, O. Stötzer, P.A. Fasching, A. Schneeweiss, P. Wimberger, S. Seiler, J. Huober, M. Thill, C. Jackisch, K. Rhiem, C. Solbach, C. Hanusch, C. Denkert, K. Engels, V. Nekljudova, S. Loibl

Publikováno v: Annals of Oncology. 33:S166-S167

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c1a96a70e56a8a94a4e8771fe9ff0ef8
https://doi.org/10.1016/j.annonc.2022.03.110